Evaluating sleep changes in patients with inflammatory bowel diseases.
Official title: Evaluation of Sleep Changes as Early Markers of Relapse in Patients With Inflammatory Bowel Diseases (IBD).
Run by Hospices Civils de Lyon · NCT05835973 · Data updated 2026-11-12
This study is trying to see if better sleep can help people with inflammatory bowel diseases, like Crohn's and ulcerative colitis, avoid flare-ups.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 216 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 4 sites (Clermont-Ferrand and 3 other locations) |
| Status | Recruiting |
| Started | April 8, 2025 |
| Main results expected | April 8, 2028 |
| Study ends | June 8, 2028 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT05835973 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 with a diagnosis of inflammatory bowel disease in remission for at least three months.
✕Probably not a fit
Patients with active complications, extensive bowel resections, or pre-existing sleep disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the relationship between sleep quality and the risk of flare-ups in patients with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Patients who have been in remission for at least three months will undergo evaluations of their IBD symptoms and sleep patterns over the course of one year. The study will utilize various methods including actigraphy, questionnaires, and clinical assessments to monitor changes in sleep efficacy and its potential predictive value for IBD flare-ups.
Why it matters
Potential benefit: If successful, this study could help identify patients at risk of flare-ups based on sleep patterns, leading to timely interventions.
How similar studies have gone: While the relationship between sleep and IBD is being explored, this specific approach to predicting flare-ups through sleep assessment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 and under 65 years of age. * Patient with Inflammatory Bowel Disease diagnosed for at least 3 months. * Patient in remission, for at least 3 months: 1. clinical remission: Harvey-Bradshaw score (HBI) \< 5 for CD and a Mayo score \< 3 for UC 2. and biological remission: absence of objective inflammation defined by CRP \< 5 mg/L and/or fecal calprotectin \< 250 µg/g. * Patient must sign informed consent form to participate to the study. * Patient affiliated to or benefiting from a social security plan. Exclusion Criteria: * Patient with complications (obstructive symptoms, fistulas or intra-abdominal abscesses in the previous three months). * Patient with extensive bowel resection (\> 40 cm of small bowel). * Patient with an ileostomy or colostomy. * Patient diagnosed with sleep disorders. * Patient without legal capacity to consent. * Pregnant, parturient or nursing women. * Persons deprived of liberty by judicial or administrative decision. * Persons under psychiatric care. * Persons admitted to a health or social institution for purposes other than research. * Persons of full age who are subject to a legal protection measure (guardianship, curators).
Where it's running
-
Lyon Sud hospital
Pierre-Bénite, France Recruiting -
CHU Clermont-Ferrand, Hôpital d'Estaing
Clermont-Ferrand, France Not yet recruiting -
CHU Grenoble Hôpital Michallon-Site Nord
Grenoble, France Not yet recruiting -
CHU Saint Etienne
Saint-Etienne, France Not yet recruiting
Study contacts
- Study coordinator: Gilles Boschetti, MD,PhD
- Email: gilles.boschetti@chu-lyon.fr
- Phone: +33 4 78 86 13 02
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis
A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.
-
Self-management program to improve health in inflammatory bowel disease
A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.
-
Cardiovascular risk in people with Crohn's disease and ulcerative colitis
This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.
-
Observational study comparing inflammatory markers in IBD and non-IBD participants
This study is trying to see how inflammation levels in people with Crohn's Disease and Ulcerative Colitis compare to those without these conditions when they start new treatments.
-
Evaluating robotic surgery for inflammatory bowel disease
This study is testing if robotic surgery can be a good option for adults with inflammatory bowel disease, like Crohn's or ulcerative colitis, compared to traditional surgery methods.
-
How nutrition and body composition relate to outcomes in people with IBD
This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.